Salesforce Shares Rise 2% After JPMorgan $250 Price Target Hints at $46 Billion Valuation Shift
13 August 2026

Salesforce Shares Rise 2% After JPMorgan $250 Price Target Hints at $46 Billion Valuation Shift

SAN FRANCISCO, August 13, 2026, 15:48 EDT — U.S. stock markets traded during regular hours.

  • Shares of Salesforce rose close to 2% after J.P. Morgan initiated coverage with an Overweight rating.
  • The bank’s $250 price target suggests a 29% potential gain by December 2027.
  • A representative re-rating could increase equity value by approximately $46 billion.

Salesforce stock climbed almost 2% on Thursday as J.P. Morgan analyst Samik Chatterjee initiated coverage with an Overweight rating. Chatterjee set a price target of $250, projecting a 29% potential gain by December 2027.

Stock chart for NYSE:CRM

The target has a significant impact on valuation. With 819 million shares as reported in July, a 29% revaluation would increase market capitalisation by about $46 billion. This figure is an example, as Salesforce’s expedited share buyback remains in progress.

The key question for investors is what needs to shift at an operational level. J.P. Morgan forecasts stronger core growth and believes AI-related risks are limited to a small segment of the business.

CatalystLatest move or valueInvestor read-through
SalesforceAlmost +2%J.P. Morgan coverage launched
J.P. Morgan target$250; 29% potential gainMarket underappreciates growth rebound
Workday +23% to $215.22Buyout report shifts software valuation
iShares Expanded Tech-Software ETF (BATS:IGV)+2.8%Broad sector recovery
S&P 500Roughly +0.7%Salesforce posted stronger performance than the index

Software shares attracted wider buying interest. Workday surged 23% following news that Silver Lake had considered a takeover, and the software ETF rose 2.8%.

The difference is significant. Workday’s action suggests there could be a control premium. Salesforce’s rise is based on an operational thesis that requires further proof.

Salesforce metricQ1 FY2027Year-on-year change
Revenue$11.13 billionUp 13%
Current RPO$33.6 billionUp 14%
Agentforce ARR$1.2 billionSurged 205%
Agentforce and Data 360 ARRAbout $3.4 billionIncrease above 200%
Non-GAAP operating margin34.8%Rising by 250 basis points

Some of the argument is backed by Salesforce’s first-quarter numbers. The company posted revenue of $11.13 billion, and current remaining performance obligations increased by 14% to $33.6 billion.

Agentforce’s ARR climbed to $1.2 billion, an increase of 205%. However, this represented only 2.7% of annualized revenue for the first quarter. Growth for the product remains rapid, though it accounts for a small portion of the total.

Chatterjee described Agentforce as “crucial” to Salesforce’s future prospects as the software sector moves to autonomous agents. He also pointed to Data 360 and Headless 360 as key drivers of growth. J.P. Morgan view reported by MarketWatch

AnalystRecommendationPrice targetDate
J.P. MorganOverweight$250Aug. 13
Morgan StanleyEqual Weight$185July 21
CLSAHold$165July 20
Evercore ISIOutperform$250July 14
Goldman SachsBuy$242July 14

Wall Street is split over when movement will occur. The latest estimates range from $165 to $250, an $85 spread that matches roughly 44% of the level the market signaled for Thursday trading.

The upcoming fiscal second-quarter results, due August 26, will mark the next test. J.P. Morgan anticipates further evidence pointing to an upturn in core growth.

Near-term hurdleCompany outlookComparison
Q2 revenue$11.27 billion–$11.35 billionStreet estimate at $11.36 billion
Q2 reported growth10%–11%Just over 4 percentage points higher than Informatica
FY2027 revenue$45.9 billion–$46.2 billionApproximately 11% growth
FY2027 free-cash-flow growthRoughly 4%–5%Cut due to impact of debt-funded buyback

Salesforce’s Q2 revenue outlook is centered at $11.31 billion, coming in just $50 million, or 0.4%, under the consensus figure. A modest beat could be enough to surpass near-term expectations.

However, the composition is more challenging. Informatica is expected to contribute just over four percentage points to second-quarter growth. With Agentforce growing, investors are looking for organic growth to pick up speed.

The balance sheet represents another consideration. Salesforce initiated an accelerated buyback of $25 billion and received approximately 103 million shares at the outset. The exact number will be determined by the settlement price of the program.

Risks: AI may accelerate the decline in seat-based software demand at a pace that Agentforce adoption does not offset. Spending on integration, reliance on debt to fund buybacks, and a soft Q2 outlook could further pressure the valuation.

Thursday’s 2% change is small compared to the 29% goal. The August 26 report will be key to revealing if Salesforce can translate AI adoption into organic bookings. That is the path to hitting $250.

TS2 TECH • EXTENDED COVERAGE

Further analysis

What caused Salesforce shares to climb today?
Salesforce stock rose close to 2% after J.P. Morgan initiated coverage, assigning an Overweight rating and a $250 price target. That target reflects a potential 29% gain through December 2027. While the wider enterprise-software recovery provided support, analysts said the upgrade was spurred specifically by J.P. Morgan's growth outlook for the company.
What is the primary metric to assess Salesforce's AI-driven growth case?
Agentforce annual recurring revenue rose to $1.2 billion, marking a 205% increase from a year earlier. However, this represented just around 2.7% of annualized revenue for the first quarter. Investors are relying on this rapid product expansion to drive up organic bookings and current remaining performance obligations. The question is when.
What are the key factors for investors to monitor in Salesforce's August 26 earnings report?
Key metrics to track include second-quarter revenue, organic growth excluding Informatica, and Agentforce adoption. Salesforce has forecast revenue in the range of $11.27 billion to $11.35 billion, which is roughly 0.4% below the Wall Street estimate at the midpoint. Surpassing expectations would be positive, but the quality of growth will be a bigger focus.
What level of disagreement do analysts have regarding Salesforce stock?
CLSA recently set its target at $165, with J.P. Morgan and Evercore ISI both at $250. Morgan Stanley's target stands at $185, and Goldman Sachs projects $242. The broad range highlights divided views on whether AI will boost Salesforce's expansion or undermine its traditional seat-based software approach.
What are the main threats to Salesforce’s stock?
The main risk is that AI could impact conventional software demand ahead of Agentforce gaining significant traction. Additional risks are weaker organic bookings, expenses from integration, debt associated with the speeded-up buyback, and valuation risk if the upcoming forecast falls short.
Leokadia Głogulska

Leokadia Głogulska is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, space technology and global market developments. She graduated from Wrocław University of Economics and Business and previously worked in financial analysis before moving into business journalism. Her reporting focuses on helping readers understand the market trends, companies and technologies shaping the global economy.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

AerCap

NYSE: AER 95 / 100
#2 BUY

Uber

NYSE: UBER 93 / 100
#3 BUY ON WEAKNESS

Taiwan Semiconductor

NYSE: TSM 91 / 100
#4 ACCUMULATE

AIG

NYSE: AIG 88 / 100
#5 BUY THE RESET

Ferguson

NYSE: FERG 86 / 100
View full portfolio
Editorial model selection. Not personalised advice.
Cardinal Health Stock Loses $912 Million as Recall Searches Test a $63.7 Billion Quarter
Previous Story

Cardinal Health Stock Loses $912 Million as Recall Searches Test a $63.7 Billion Quarter

DEFSEC Stock Surges 86% as Revenue Nearly Doubles, but Dilution Risk Lingers
Next Story

DEFSEC Stock Surges 86% as Revenue Nearly Doubles, but Dilution Risk Lingers